Palisade Bio (PALI) EPS (Basic) Growth (5y) (2015 - 2026)
Palisade Bio (PALI) EPS (Basic) Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Palisade Bio |
391.02 Mn |
261.45 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
42.42% |
| Dec 31, 2025 |
22.03% |
| Sep 30, 2025 |
10.45% |
| Jun 30, 2025 |
2.84% |
| Mar 31, 2025 |
39.03% |
| Dec 31, 2024 |
-21.89% |
| Sep 30, 2024 |
-31.50% |
| Jun 30, 2024 |
-18.02% |
| Mar 31, 2024 |
-6.06% |
| Dec 31, 2023 |
-20.89% |
| Sep 30, 2023 |
-25.09% |
| Jun 30, 2023 |
-57.05% |
| Mar 31, 2023 |
-125.32% |
| Dec 31, 2022 |
62.55% |
| Sep 30, 2022 |
-233.09% |
| Jun 30, 2022 |
-71.40% |
| Mar 31, 2022 |
-80.31% |
| Dec 31, 2021 |
-200.41% |
| Sep 30, 2021 |
22.08% |
| Jun 30, 2021 |
-50.18% |
